Antiatherogenic effects of S-nitroso-N-acetylcysteine in hypercholesterolemic LDL receptor knockout mice

Nitric Oxide - Biology and Chemistry

Volumn 14, Issue 1, 2006, Pages 12-20

  Krieger, M H ^a   Santos, K F R ^a   Shishido, S M ^a   Wanschel, A C B A ^a   Estrela, H F G ^a   Santos, L ^a   De Oliveira, M G ^a   Franchini, K G ^a   Spadari Bratfisch, R C ^a   Laurindo, F R M ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atherosclerosis; Deficient receptor LDL knockout mice; Endothelial dysfunction; Nitric oxide; Nitric oxide synthases; Nitrosothiol; Oxidative stress

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE DERIVATIVE; CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; N ACETYL S NITROSOCYSTEINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SUPEROXIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DRUG EFFECT; HYPERCHOLESTEROLEMIA; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR LESION; VASODILATATION; VASOMOTOR DISORDER;

ANIMALIA;

EID: 30344432699     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.07.011     Document Type: Article

References (47)

1. A.J. Maxwell Mechanism of dysfunction of the nitric oxide pathway in vascular diseases Nitric Oxide: Biol. Chem. 6 2002 101 124
2. K. Kauser, V. Cunha, and R. Fitch Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E deficient mice Am. J. Physiol. Heart Circ. Physiol. 278 2000 H1679 H1685
3. J.T. Kuvin, and R.H. Karas Clinical utility of endothelial function testing. Ready for prime time? Circulation 107 2003 3243 3247
4. H. Drexler Nitric oxide and coronary endothelial dysfunction in human Cardiovasc. Res. 43 1999 572 579
5. J.W. Meyer, and M.E. Schmitt A central role for the endothelial NADPH oxidase in atherosclerosis FEBS Lett. 472 2000 1 4
6. G. Kodja, and D. Harrison Interactions between NO and reactivity oxygen species: pathophysiological importance in atherosclerosis, hypertension diabetes and heart failure Cardiovasc. Res. 43 1999 562 571
7. H. Cai, and D.G. Harrison Endothelial dysfunction in cardiovascular disease. The role of oxidant stress Circ. Res. 87 2000 840 844
8. D. Harrison, K.K. Griendling, U. Landmesser, B. Horning, and H. Drexler Role of oxidative stress in atherosclerosis Am. J. Cardiol. 91 2003 7A 11A
9. C. Kunsh, and R.M. Meldford Oxidative stress as a regulator of gene expression in the vasculature Circ. Res. 85 1999 753 766
10. M.I. Cybulsky, A. Lichtman, L. Hajra, and I. Iyama Leukocyte adhesion molecules in atherogenesis Clin. Chim. Acta 286 1999 207 218
11. A. Lusis Atherosclerosis Nature 407 2000 333 341
12. H. Li, and U. Forstermann Nitric oxide in the pathogenesis of vascular disease J. Pathol. 190 2000 244 254
13. M.G. Espey, K.M. Miranda, and D.D. Thomas A chemical perspective on the interplay between NO, reactive oxygen species, and reactive nitrogen oxide species Ann. N.Y. Acad. Sci. 962 2002 195 206
14. P. Carmeliet, L. Moons, and D. Collen Mouse models of angiogenesis, arterial stenosis, atherosclerosis and homeostasis Cardiovasc. Res. 39 1 1998 8 33
15. T.A. McCaffrey, C. Fu, and B.D. Eksinar High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis J. Clin. Invest. 105 2000 653 662
16. B. Gaston Nitric oxide and thiol groups Biochem. Biophys. Acta 1411 1999 323 333
17. N. Hoog Biological chemistry and clinical potential of S-nitrosothiol Free Radic. Biol. Med. 28 2000 14878 14886
18. K.F.R. Santos, S.M. Shishido, and M.G. De Oliveira Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine (SNAC) in normotensive and hypertensive conscious rats Nitric Oxide: Biol. Chem. 7 2002 57 66
19. S. Ishibashi, M.S. Brown, and J.L. Goldtein Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus mediated gene delivery J. Clin. Invest. 92 1993 883 893
20. J.M. Van Rossum Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of the drug parameters Arch. Inter. Pharmacodyn. 143 1963 229 330
21. T. Kenakin Analysis of dose-response data. In: Pharmacologic Analysis of Drug-Receptor Interaction second ed. 1993 Raven Press New York pp. 176-220
22. F.R.M. Laurindo, H.P. Souza, and M.P. Pedro Redox aspects of vascular response to injury Methods Enzymol. 352 2002 432 454
23. M.M. Bradford A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
24. B. Paigen, A. Morrow, and P.A. Holmes Quantitative assessment of atherosclerotic lesions in mice Atherosclerosis 68 1987 231 236
25. E.M. Rubin, R.M. Krauss, and E.A. Spangler Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 1991 265 267
26. S. Jiao, T.G. Cole, and R.T. Kitchens Genetic heterogeneity of lipoprotein in inbred strains of mice: analysis by gel-permeation chromatography Metabolism 39 1990 45 57
27. R.C. Tambascia, P.M. Fonseca, and P.D.C. Corat Expression and distribution of NOS1 and NOS3 in the myocardium of angiotensin II-infused rats Hypertension 37 2001 1423 1428
28. P.C. Faggiotto, R. Ross, and L. Hasker Studies of hypercholesterolemia in the nonhuman primate. Changes that lead to fatty streak formation Atherosclerosis 4 1984 323 340
29. J.F. Keaney, A. Xu, and D. Cunningham Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation J. Clin. Invest. 95 1995 2520 2529
30. K.G. Lamping, R.W. Nuno, and D.A. Chappell Agonist-specific impaired of coronary vascular function in genetically altered, hyperlipidemic mice Am. J. Physiol. Regul. Integr. Comp. Physiol. 4 1999 R1023 R1029
31. K.M. Channon, H. Qian, and S.E. George Nitric oxide in atherosclerosis and vascular injury Arterioscler. Throm. Vasc. Biol. 20 2000 1873 1881
32. R.L. Minor, P.R. Myers, and R. Guerra Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta J. Clin. Invest. 86 1990 2109 2116
33. K.A. Pritchard, L. Grosek, and D.M. Smalley Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion Circ. Res. 77 1995 510 518
34. P.J. Kuhlencordt, R. Gyurko, and F. Han Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 2001 448 454
35. R.V. van Haperen, M. de Waard, and E. van Deel Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide J. Biol. Chem. 277 2002 48803 48807
36. W. Shi, X. Wang, and D.M. Shih Paradoxical reduction of fatty streak formation in mice lacking endothelial nitric oxide synthase Circulation 105 2002 2078 2082
37. J. Chen, P.J. Kuhlencordt, and J. Astern Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein/endothelial nitric oxide synthase double knockout mice Circulation 104 2001 2391 2394
38. M. Ozaki, S. Kawashima, and T. Yamashita Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice J. Clin. Invest. 119 2002 331 340
39. J.N. Wilcox, R.R. Subramian, and C.L. Sundel Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels Arterioscler. Throm. Vasc. 17 1997 2479 2488
40. C.M. Boulanger, C. Heymes, and J. Benessiano Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells Circ. Res. 83 1998 1271 1278
41. J.C. Sullivam, A.D. Giulumian, and D.M. Pollok Functional NOS1 in the rat mesenteric arterial bed Am. J. Physiol. Heart Circ. Physiol. 283 2002 H658 H663
42. L.S. Cheah, M.C.E. Gwee, and R. Ras Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle Clin. Exp. Pharmacol. Physiol. 29 2002 725 727
43. P.M. Schwarz, H. Kleinert, and N. Förstermann Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta Arterioscler. Thromb. Vasc. Biol. 19 1999 2584
44. L. Walch, C. Brink, and X. Norel The muscarinic receptor subtypes in human blood vessels Therapie 56 2001 223 226
45. Y. Mita, K. Dobashi, and M. Moriss Induction of muscarinic receptor subtypes in monocytes/macrophagic cells differentiated from EoL-1 cells Eur. J. Pharmacol. 297 1996 121 127
46. C.E. Sears, S.M. Bryant, and A. Euan Cardiac neuronal nitric oxide synthase isoform regulated myocardial contraction and calcium handling Circ. Res. 92 2003 E52 E59
47. R.P. Brandes, S.-W. Friedrich-Hubertus, and M. Félétou An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice Proc. Natl. Acad. Sci. USA 15 2000 9747 9752